News & Trends - Pharmaceuticals
La Trobe awarded $2.6 million towards research aimed at reducing hospital admissions
La Trobe University researchers working on reducing hospital admissions for patients with knee osteoarthritis or chronic obstructive pulmonary disease (COPD) have secured $2.6 million over three years from the Medical Research Future Fund’s “Keeping Australians out of Hospital” scheme, announced today by Federal Health Minister Greg Hunt.
La Trobe Deputy Vice-Chancellor (Research and Industry Engagement) Professor Susan Dodds welcomed the announcement.
“La Trobe has long focused on innovative problem-solving for community benefit,” Professor Dodds said.
“Keeping people healthy, out of hospital and active in their communities as they age is important to us too. That’s why we are particularly proud of these grants which will ultimately improve healthcare and quality of life across the nation.”
The Projects
Reducing inappropriate knee replacement surgery
Dr Christian Barton, MRFF TRIP Fellow, La Trobe Sport and Exercise Medicine Research Centre, School of Allied Health, Human Services and Sport $1.34 million over three years
Dr Barton leads a team investigating whether improved access to physiotherapy for people with knee osteoarthritis, who have been referred for potential surgery, results in fewer operations. The project will explore strategies to improve physiotherapy access for all Australians.
Dr Barton said Australia currently spends more than $1.2 billion a year on knee joint replacements. That figure is estimated to pass $3 billion in the next 10-15 years.
“This cost is not sustainable in our healthcare system. We already know that physiotherapist-led nonsurgical care can delay joint replacement by two years in two thirds of people. Our trial will look at the costs, impacts and barriers to providing non-surgical care for people on knee-replacement waiting lists or who have been referred to see a surgeon,” Dr Barton said.
Transforming pulmonary rehabilitation to reduce hospital admissions in COPD
Professor Anne Holland, Academic and Research Collaborative in Health (ARCH) Chair, Alfred Health, School of Allied Health, Human Services and Sport $1.22 million over three years
About half a million Australians have COPD and experience distressing breathlessness, often resulting in a hospital stay. Professor Holland leads a team that has developed a low-cost home-based rehabilitation model based around exercise training to cut hospital admissions.
Professor Holland said today’s funding announcement provides a unique opportunity to take the pulmonary rehabilitation model from research into real world clinical practice.
“We will partner with 14 pulmonary rehabilitation programs across Australia to find out whether making participation in rehabilitation easier improves wellbeing for people with chronic lung disease, and reduces hospital admissions and healthcare costs. This is a key step towards more accessible and affordable care for people with COPD in Australia,” Professor Holland said.
La Trobe’s partners in this project are Lung Foundation Australia, Thoracic Society of Australia and New Zealand, and the Institute for Breathing and Sleep.
You may also like PBS listing for end of life care and opioid dependency effective 1 September
News & Trends - Pharmaceuticals
Government inaction on mental illness faces overwhelming criticism ahead of federal election
Pharma News: The Federal Government must strengthen its support for individuals with severe and complex mental illness to prevent future […]
MoreNews & Trends - Pharmaceuticals
New CVD model marks a critical step in the right direction
Pharma News: Cardiovascular disease (CVD) affects four million Australians and claims one life every 12 minutes. A recent heart screening […]
MoreNews & Trends - Pharmaceuticals
Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation
Pharma News: A newly commissioned report by Lilly, unveiled at Parliament House, has shed light on the health, societal, and […]
MoreLeadership & Management
J&J MedTech appoints new ANZ leader
Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and […]
More